Inhibition of erythrocyte aggregation by the silicates is reversed by masking the erythrocyte sulphydryl groups.
Ramsohoye
P V
PV
Babraham Institute, Cambridge, UK.
Fritz
I B
IB
D002731:4-Chloromercuribenzenesulfonate / Q000494:pharmacology; D002449:Cell Aggregation / Q000187:drug effects*; D004912:Erythrocytes / Q000187:drug effects / Q000502:physiology*; D005033:Ethylmaleimide / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D017640:Silicates / Q000494:pharmacology*; D013438:Sulfhydryl Compounds / Q000097:blood; D013439:Sulfhydryl Reagents / Q000494:pharmacology*
D017640:Silicates; D013438:Sulfhydryl Compounds; D013439:Sulfhydryl Reagents; D002731:4-Chloromercuribenzenesulfonate; C005691:sodium silicate; D005033:Ethylmaleimide